Login / Signup

How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)?

Giuseppe FlorestaChiara ZagniVincenzo PatamiaAntonio Rescifina
Published in: Expert opinion on drug discovery (2023)
Keyphrases
  • artificial intelligence
  • sars cov
  • machine learning
  • big data
  • deep learning
  • respiratory syndrome coronavirus
  • coronavirus disease
  • adverse drug
  • drug induced
  • emergency department